QIAGEN NV EO -,01 | 44.270 / -1.18% |
Date/Time | 01/22 / 08:10 |
Chg. / Chg.(%) | -0.530 / -1.18% |
Bid | - |
Ask | - |
Open | 44.270 |
Previous Close | 44.800 |
High | 44.270 |
Low | 44.270 |
Volume [EUR] | 0.000 |
Volume [Units] | 0 |
Price fixings | 1 |
ISIN | NL0012169213 |
Security | QIA |
Exchange | Hannover |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 44.690 | ![]() |
|
Xetra | 44.900 | ![]() |
628,887 |
NYSE | 54.33 | ![]() |
536,634 |
Turquoise | 44.85 | ![]() |
156,458 |
Cboe Europe .. | 44.90 | ![]() |
115,243 |
London Inter.. | 44.80 | ![]() |
62,088 |
Cboe US | 54.31 | ![]() |
22,316 |
Frankfurt | 44.9700 | ![]() |
13,408 |
TradeGate | 44.85 | ![]() |
11,197 |
IEX | 54.34 | ![]() |
6,975 |
Stuttgart | 44.700 | ![]() |
1,472 |
Hamburg | 44.620 | ![]() |
518 |
gettex | 44.860 | ![]() |
355 |
Cboe Europe .. | 44.90 | ![]() |
300 |
Cboe Europe .. | 44.64 | ![]() |
200 |
Düsseldorf | 44.780 | ![]() |
179 |
Vienna Globa.. | 44.82 | ![]() |
0 |
München | 44.470 | ![]() |
0 |
Hannover | 44.270 | ![]() |
0 |
Berlin | 44.330 | ![]() |
0 |
EUREX | Options |
News
- OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
12/09/2020 / 13:30 - GlobeNewswire - HTG Molecular Diagnostics Reports Third Quarter 2020 Results
11/10/2020 / 22:01 - GlobeNewswire - Ellume Secures $30M from National Institutes of Health RADx Initiative to Accelerate Development of Rapid COVID-19 Diagnostics
10/06/2020 / 21:30 - GlobeNewswire - Thermo Fisher's acquisition of Qiagen fails
08/13/2020 / 13:48 - TeleTrader - HTG Molecular Diagnostics Reports Second Quarter 2020 Results
08/11/2020 / 22:01 - GlobeNewswire